CC-1088

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

CC-1088 is a thalidomide analogue inhibitor of phosphodiesterase 4 that was being developed up to 2005 by Celgene Corp., for treating of inflammatory diseases and myelodysplastic syndromes. Apremilast (CC-10004) was found to be a preferable.

CC-1088 is a thalidomide analogue inhibitor of phosphodiesterase 4 that was being developed up to 2005 by Celgene Corp., for treating of inflammatory diseases and myelodysplastic syndromes. Apremilast (CC-10004) was found to be a preferable.

See also

Apremilast Development of analogs of thalidomide

References

External links

NCI Thesaurus

Text derived from https://en.wikipedia.org/w/index.php?oldid=1297112918 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001297112918 · captured 1750738737.0 · version history

Cite this page as: encyclopegia.org, “CC-1088”, snapshot enwiki-001297112918. https://encyclopegia.org/a/cc-1088

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.